|
Up until now, freezing and testing of PBMC has required the use of serum. Serum
contains a plethora of bioactive molecules whose variable concentrations render
each batch unique. Each lot must therefore be tested, which makes working with
serum both expensive and time-consuming.
CTL scientists have formulated a revolutionary
new media portfolio that permits each step of the ex vivo PBMC work to
be performed without serum.
When frozen in accordance with CTL protocols, PBMC maintain their full
functionality in ELISPOT assays.
more...
|